Cargando…

Evaluation of the protection conferred by a naturally attenuated Neospora caninum isolate against congenital and cerebral neosporosis in mice

The parasite Neospora caninum is an important abortifacient agent in cattle worldwide. At present, the development of an effective and safe vaccine against bovine neosporosis is of great relevance. Recently, a new isolate of N. caninum (Nc-Spain 1 H) which was obtained from the brain of an asymptoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojo-Montejo, Silvia, Collantes-Fernández, Esther, López-Pérez, Inmaculada, Risco-Castillo, Verónica, Prenafeta, Antoni, Ortega-Mora, Luis Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468385/
https://www.ncbi.nlm.nih.gov/pubmed/22913428
http://dx.doi.org/10.1186/1297-9716-43-62
_version_ 1782245941339750400
author Rojo-Montejo, Silvia
Collantes-Fernández, Esther
López-Pérez, Inmaculada
Risco-Castillo, Verónica
Prenafeta, Antoni
Ortega-Mora, Luis Miguel
author_facet Rojo-Montejo, Silvia
Collantes-Fernández, Esther
López-Pérez, Inmaculada
Risco-Castillo, Verónica
Prenafeta, Antoni
Ortega-Mora, Luis Miguel
author_sort Rojo-Montejo, Silvia
collection PubMed
description The parasite Neospora caninum is an important abortifacient agent in cattle worldwide. At present, the development of an effective and safe vaccine against bovine neosporosis is of great relevance. Recently, a new isolate of N. caninum (Nc-Spain 1 H) which was obtained from the brain of an asymptomatic congenitally infected calf, exhibited non-virulent behaviour in mouse and bovine infection models. The aim of this study was to determine the safety and efficacy of Nc-Spain 1 H when used as a vaccinal isolate in well-established BALB/c models of congenital and cerebral neosporosis. Mice were subcutaneously immunised twice at 3-week intervals and were challenged with 2 × 10(6) tachyzoites of the virulent Nc-Liv isolate. After immunisation with live Nc-Spain 1 H tachyzoites, no parasitic DNA was detected in the dams’ brains before challenge and microsatellite analysis performed in PCR-positive mice showed that the profiles corresponded to the challenge isolate Nc-Liv, indicating the Nc-Spain 1 H isolate to be a safe vaccine candidate. The efficacy of the live vaccine was evaluated in the first experiment after the immunisation of mice with 5 × 10(5) live Nc-Spain 1 H tachyzoites. This immunisation protocol significantly reduced the neonatal mortality to 2.4%, reduced the vertical transmission from 89.1% to 2.3% and completely limited the cerebral infection. These results were associated with a Th1-type immune response. In the second experiment, the effect of various immunising doses was established using ten-fold dilutions of the tachyzoites (from 5 × 10(5) to 5 × 10). In all the cases, congenital protection rates above 60% were observed, and the mice that were immunised with the lowest dose (5 × 10) presented the highest protection rate (86%). Moreover, low immunising doses of Nc-Spain 1 H induced an IgG2a response, and high parasitic doses induced an IgG1 response. These results evidence the safety and the efficient protection that was conferred by Nc-Spain 1 H against congenital neosporosis, even when the mice were immunised with low parasitic doses.
format Online
Article
Text
id pubmed-3468385
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34683852012-10-11 Evaluation of the protection conferred by a naturally attenuated Neospora caninum isolate against congenital and cerebral neosporosis in mice Rojo-Montejo, Silvia Collantes-Fernández, Esther López-Pérez, Inmaculada Risco-Castillo, Verónica Prenafeta, Antoni Ortega-Mora, Luis Miguel Vet Res Research The parasite Neospora caninum is an important abortifacient agent in cattle worldwide. At present, the development of an effective and safe vaccine against bovine neosporosis is of great relevance. Recently, a new isolate of N. caninum (Nc-Spain 1 H) which was obtained from the brain of an asymptomatic congenitally infected calf, exhibited non-virulent behaviour in mouse and bovine infection models. The aim of this study was to determine the safety and efficacy of Nc-Spain 1 H when used as a vaccinal isolate in well-established BALB/c models of congenital and cerebral neosporosis. Mice were subcutaneously immunised twice at 3-week intervals and were challenged with 2 × 10(6) tachyzoites of the virulent Nc-Liv isolate. After immunisation with live Nc-Spain 1 H tachyzoites, no parasitic DNA was detected in the dams’ brains before challenge and microsatellite analysis performed in PCR-positive mice showed that the profiles corresponded to the challenge isolate Nc-Liv, indicating the Nc-Spain 1 H isolate to be a safe vaccine candidate. The efficacy of the live vaccine was evaluated in the first experiment after the immunisation of mice with 5 × 10(5) live Nc-Spain 1 H tachyzoites. This immunisation protocol significantly reduced the neonatal mortality to 2.4%, reduced the vertical transmission from 89.1% to 2.3% and completely limited the cerebral infection. These results were associated with a Th1-type immune response. In the second experiment, the effect of various immunising doses was established using ten-fold dilutions of the tachyzoites (from 5 × 10(5) to 5 × 10). In all the cases, congenital protection rates above 60% were observed, and the mice that were immunised with the lowest dose (5 × 10) presented the highest protection rate (86%). Moreover, low immunising doses of Nc-Spain 1 H induced an IgG2a response, and high parasitic doses induced an IgG1 response. These results evidence the safety and the efficient protection that was conferred by Nc-Spain 1 H against congenital neosporosis, even when the mice were immunised with low parasitic doses. BioMed Central 2012 2012-08-22 /pmc/articles/PMC3468385/ /pubmed/22913428 http://dx.doi.org/10.1186/1297-9716-43-62 Text en Copyright ©2012 Rojo-Montejo et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Rojo-Montejo, Silvia
Collantes-Fernández, Esther
López-Pérez, Inmaculada
Risco-Castillo, Verónica
Prenafeta, Antoni
Ortega-Mora, Luis Miguel
Evaluation of the protection conferred by a naturally attenuated Neospora caninum isolate against congenital and cerebral neosporosis in mice
title Evaluation of the protection conferred by a naturally attenuated Neospora caninum isolate against congenital and cerebral neosporosis in mice
title_full Evaluation of the protection conferred by a naturally attenuated Neospora caninum isolate against congenital and cerebral neosporosis in mice
title_fullStr Evaluation of the protection conferred by a naturally attenuated Neospora caninum isolate against congenital and cerebral neosporosis in mice
title_full_unstemmed Evaluation of the protection conferred by a naturally attenuated Neospora caninum isolate against congenital and cerebral neosporosis in mice
title_short Evaluation of the protection conferred by a naturally attenuated Neospora caninum isolate against congenital and cerebral neosporosis in mice
title_sort evaluation of the protection conferred by a naturally attenuated neospora caninum isolate against congenital and cerebral neosporosis in mice
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468385/
https://www.ncbi.nlm.nih.gov/pubmed/22913428
http://dx.doi.org/10.1186/1297-9716-43-62
work_keys_str_mv AT rojomontejosilvia evaluationoftheprotectionconferredbyanaturallyattenuatedneosporacaninumisolateagainstcongenitalandcerebralneosporosisinmice
AT collantesfernandezesther evaluationoftheprotectionconferredbyanaturallyattenuatedneosporacaninumisolateagainstcongenitalandcerebralneosporosisinmice
AT lopezperezinmaculada evaluationoftheprotectionconferredbyanaturallyattenuatedneosporacaninumisolateagainstcongenitalandcerebralneosporosisinmice
AT riscocastilloveronica evaluationoftheprotectionconferredbyanaturallyattenuatedneosporacaninumisolateagainstcongenitalandcerebralneosporosisinmice
AT prenafetaantoni evaluationoftheprotectionconferredbyanaturallyattenuatedneosporacaninumisolateagainstcongenitalandcerebralneosporosisinmice
AT ortegamoraluismiguel evaluationoftheprotectionconferredbyanaturallyattenuatedneosporacaninumisolateagainstcongenitalandcerebralneosporosisinmice